Hudson Bay Capital Management LP Zentalis Pharmaceuticals, Inc. Transaction History
Hudson Bay Capital Management LP
- $25.7 Billion
- Q2 2025
A detailed history of Hudson Bay Capital Management LP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 16,638 shares of ZNTL stock, worth $21,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,638
Previous 16,638
-0.0%
Holding current value
$21,962
Previous $19,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ZNTL
# of Institutions
120Shares Held
60.4MCall Options Held
0Put Options Held
22K-
Matrix Capital Management Company, LP Waltham, MA14MShares$18.4 Million8.42% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$6.36 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.48MShares$4.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$3.81 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.8MShares$3.69 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $75.2M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...